Research progress on natural β-glucan in intestinal diseases
Xiaoqin Han,Ruifeng Luo,Naijing Ye,Yichen Hu,Chaomei Fu,Ru Gao,Shu Fu,Fei Gao
DOI: https://doi.org/10.1016/j.ijbiomac.2022.08.173
IF: 8.2
2022-10-31
International Journal of Biological Macromolecules
Abstract:β-Glucan, an essential natural polysaccharide widely distributed in cereals and microorganisms, exhibits extensive biological activities, including immunoregulation, anti-inflammatory, antioxidant, antitumor properties, and flora regulation. Recently, increasing evidence has shown that β-glucan has activities that may be useful for treating intestinal diseases, such as inflammatory bowel disease (IBD), and colorectal cancer. The advantages of β-glucan, which include its multiple roles, safety, abundant sources, good encapsulation capacity, economic development costs, and clinical evidence, indicate that β-glucan is a promising polysaccharide that could be developed as a health product or medicine for the treatment of intestinal disease. Unfortunately, few reports have summarized the progress of studies investigating natural β-glucan in intestinal diseases. This review comprehensively summarizes the structure-activity relationship of β-glucan, its pharmacological mechanism in IBD and colorectal cancer, its absorption and transportation mechanisms, and its application in food, medicine, and drug delivery, which will be beneficial to further understand the role of β-glucan in intestinal diseases.
polymer science,biochemistry & molecular biology,chemistry, applied